FDA asks Emergent plant behind botched COVID-19 vaccines to pause manufacturing
(Reuters) -The U.S. Food and Drug Administration has asked Emergent BioSolutions Inc to halt producing new materials for COVID-19 vaccines until the regulator completes an […]
Continue reading »